Ceva producing aMPV experimental autogenous vaccine using US-origin isolate
Ceva Animal Health has started antigen production for an experimental autogenous vaccine to fight the emerging avian metapneumovirus (aMPV) disease.
Ceva Animal Health has started antigen production for an experimental autogenous vaccine to fight the emerging avian metapneumovirus (aMPV) disease.
Day-old birds immunized with vaccines for Georgia (GA) and Massachusetts (Mass) serotypes of infectious bronchitis virus (IBV) were shown to be protected against four other circulating IBV variants in a recent study.
A new vaccine-application approach shows advantages to help make on-farm, day-of-age vaccination easier to perform while increasing effectiveness.
Modern Poultry is pleased to host
this editorial page on behalf of
Copyright ©Feeks Media LLC, 2024 | All rights reserved
info@modernpoultry.media
privacy policy | site map